By Dean Seal
Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer.
The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of corporate development.
He succeeds Brian Di Donato, who told the company over the summer he would step down by the end of the year to take a role as chief executive at an early-stage biotech firm based in San Diego.
Coy was previously the head of transactions and mergers and acquisitions at Eli Lilly. He has served as non-executive director of Immunocore since September 2019.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 02, 2025 07:34 ET (12:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。